Elliptic Laboratories ASA
OSE:ELABS.OL
17.56 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.884 | 22.232 | 9.216 | 21.874 | 33.18 | 4.05 | 9.848 | 27.077 | 9.621 | 5.516 | 34.669 | 13.401 | 4.809 | 1.719 | 24.071 | 3.538 | 2.289 | 0.002 | 7.726 |
| Cost of Revenue
| 17.136 | 24.34 | 24.455 | 20.572 | 19.28 | 18.939 | 16.935 | 16.341 | 15.628 | 13.898 | 18.784 | 13.606 | 8.084 | 10.333 | 5.225 | 9.414 | 8.924 | 12.303 | 6.666 |
| Gross Profit
| 16.748 | -2.108 | -15.239 | 1.302 | 13.9 | -14.889 | -7.087 | 10.736 | -6.007 | -8.382 | 15.885 | -0.205 | -3.275 | -8.614 | 18.846 | -5.876 | -6.635 | -12.3 | 1.061 |
| Gross Profit Ratio
| 0.494 | -0.095 | -1.654 | 0.06 | 0.419 | -3.676 | -0.72 | 0.396 | -0.624 | -1.52 | 0.458 | -0.015 | -0.681 | -5.01 | 0.783 | -1.661 | -2.899 | -5,452.349 | 0.137 |
| Reseach & Development Expenses
| 3.536 | 3.537 | 2.896 | 2.897 | 2.897 | 2.897 | 2.035 | 2.036 | 1.875 | 2.195 | 1.426 | 1.426 | 1.425 | 1.426 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 1.7 | 1.784 | 2.217 | 2.56 | 1.519 | 1.411 | 0.863 | 1.756 | 1.945 | 3.412 | 0.555 | 0.917 | 0.698 | 1.285 | 2.02 | 1.302 | 0.982 | 1.187 |
| Selling & Marketing Expenses
| 0 | 1.982 | 2.433 | 2.029 | 2.296 | 1.959 | 1.577 | 1.386 | 1.117 | 1.304 | 1.61 | 0.995 | 1.017 | 0.999 | 1.327 | 0.872 | 0.633 | 0.901 | 1.489 |
| SG&A
| 0.535 | 2.719 | 4.838 | 4.246 | 4.856 | 3.478 | 2.988 | 2.249 | 2.873 | 3.249 | 5.022 | 1.55 | 1.934 | 1.697 | 2.611 | 2.892 | 1.936 | 1.883 | 2.677 |
| Other Expenses
| 9.777 | 0 | 0 | 0 | 6.864 | 5.757 | 5.729 | 4.981 | 4.646 | 4.677 | 3.206 | 0.705 | 0.573 | 0.245 | -0.945 | -1.194 | -0.865 | -1.752 | 0.379 |
| Operating Expenses
| 10.312 | 6.256 | 7.734 | 10.853 | 11.72 | 9.235 | 8.717 | 7.23 | 7.519 | 7.926 | 8.228 | 2.255 | 2.507 | 1.942 | 1.667 | 1.698 | 1.071 | 0.131 | 5.613 |
| Operating Income
| 6.436 | -8.364 | -22.973 | -7.372 | 4.475 | -24.126 | -15.803 | 10.954 | -13.525 | -16.309 | 7.658 | -2.46 | -5.782 | -10.556 | 17.178 | -7.575 | -7.707 | -12.432 | -4.174 |
| Operating Income Ratio
| 0.19 | -0.376 | -2.493 | -0.337 | 0.135 | -5.957 | -1.605 | 0.405 | -1.406 | -2.957 | 0.221 | -0.184 | -1.202 | -6.139 | 0.714 | -2.141 | -3.367 | -5,510.54 | -0.54 |
| Total Other Income Expenses Net
| -0.237 | 5.204 | -2.844 | -1.246 | 1.537 | 5.692 | -7.227 | -2.532 | 6.301 | -1.161 | 1.612 | -0.788 | -0.438 | -0.464 | 1.043 | -0.732 | -0.256 | -1.454 | -0.129 |
| Income Before Tax
| 6.199 | -3.16 | -25.817 | -8.618 | 6.012 | -18.434 | -23.03 | 8.422 | -7.224 | -17.47 | 6.806 | -2.658 | -6.22 | -11.02 | 14.165 | -8.307 | -7.962 | -13.886 | -4.681 |
| Income Before Tax Ratio
| 0.183 | -0.142 | -2.801 | -0.394 | 0.181 | -4.552 | -2.339 | 0.311 | -0.751 | -3.167 | 0.196 | -0.198 | -1.293 | -6.409 | 0.588 | -2.348 | -3.479 | -6,155.098 | -0.606 |
| Income Tax Expense
| 1.448 | -0.544 | -5.644 | -1.69 | 2.015 | -3.537 | -3.93 | 1.674 | -0.872 | -3.176 | 2.483 | -0.567 | -1.327 | -2.467 | 3.273 | -1.619 | -1.804 | -3.055 | -1.119 |
| Net Income
| 4.751 | -2.616 | -20.173 | -6.928 | 3.997 | -14.897 | -19.1 | 6.748 | -6.352 | -14.294 | 4.324 | -2.091 | -4.894 | -8.553 | 10.892 | -6.688 | -6.159 | -10.831 | -3.562 |
| Net Income Ratio
| 0.14 | -0.118 | -2.189 | -0.317 | 0.12 | -3.678 | -1.939 | 0.249 | -0.66 | -2.591 | 0.125 | -0.156 | -1.018 | -4.975 | 0.452 | -1.89 | -2.691 | -4,800.976 | -0.461 |
| EPS
| 0.04 | -0.025 | -0.19 | -0.066 | 0.038 | -0.14 | -0.18 | 0.06 | -0.061 | -0.14 | 0.042 | -0.02 | -0.051 | -0.09 | 0.12 | -0.07 | -0.064 | -0.081 | -0.037 |
| EPS Diluted
| 0.04 | -0.025 | -0.19 | -0.066 | 0.038 | -0.14 | -0.18 | 0.06 | -0.06 | -0.14 | 0.042 | -0.02 | -0.051 | -0.09 | 0.12 | -0.07 | -0.064 | -0.081 | -0.037 |
| EBITDA
| 11.422 | -6.941 | -21.567 | -4.879 | 8.337 | -13.863 | -23.97 | 13.682 | -3.651 | -12.809 | 7.29 | 0.213 | -2.794 | -8.293 | 14.489 | -5.005 | -5.423 | -11.063 | -1.916 |
| EBITDA Ratio
| 0.337 | -0.312 | -2.34 | -0.223 | 0.251 | -3.423 | -2.434 | 0.505 | -0.379 | -2.322 | 0.21 | 0.016 | -0.581 | -4.823 | 0.602 | -1.415 | -2.369 | -4,903.722 | -0.248 |